DHT Holdings Inc. vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? DHT Holdings Inc. trades at $24.91 (market cap $3.82B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and DHT Holdings Inc. pays a 20.58% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold DHT Holdings Inc. for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| DHT | IOVA | |
|---|---|---|
Market Cap | $3.82B | $5.85B |
Volume | 3,845,643 | 14,517,176 |
Sector | Industrials | Health |
52-Week High | $24.93 | $14.82 |
52-Week Low | $11.20 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.10B | $5.78B |
Dividend Yield | 20.58% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
DHT Holdings operates a fleet of crude oil tankers that trade on international routes. Its fleet consists of very large crude carriers, or VLCCs.
Read more on DHT →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →